Professional Documents
Culture Documents
ISSN 2250-3153
18
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
19
REFERENCES
[1]
[2]
[3]
[4]
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and
morbidity in early-stage breastcancer patients after breast-conservation
treatment. J ClinOncol 2006;24:41004106.
Jagsi R, Griffith KA, Koelling T, et al. Rates of myocardial infarction and
coronary artery diseaseand risk factors in patients treated with radiation
therapy for early-stage breast cancer. Cancer2007;109:650657.
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of
differences in the extent of surgery for early breast cancer on local
recurrence and 15-year survival: an overview of randomised trials. Lancet.
2005;366:2087-2106.
Mary Feng, Jean M. Moran, Todd Koelling, AamerChughtai, June L. Chan,
Laura Freedman ,et al. Development and validation of a heart atlas to study
cardiac exposure to radiation following treatment for breast cancer. Int J
RadiatOncolBiol Phys. 2011 January 1; 79(1): 1018.
Sarah C. Darby, Marianne Ewertz, Paul McGale, Anna M. Bennet, Ulla
Blom-Goldman, DortheBrnnum ,et al . Risk of Ischemic Heart Disease in
Women after Radiotherapy for Breast Cancer. N Engl J Med 2013;368:98798.
Darby SC, McGale P, Taylor CW, Peto R. Long-termmortality from heart
disease and lung cancer afterradiotherapy for early breast cancer:
prospective cohortstudy of about 300,000 women in US SEER
cancerregistries. Lancet Oncol2005; 6: 55765.
Hurksman CW,ChoBC,DamenE,etal.Reduction of cardiac and lung
complication probabilities after breast irradiation using conformal
radiotherapy
with
or
without
intensity
modulation.Radiother
Oncol.2002;62:163-71
Kruger EA ,FraassBA,PierceLJ.Clinical Aspect of intensity modulated
radiotherapy in the treatment of breast cancer.SeminRadiat
Oncol.2002;12(3):250-9.
Offersen B ,Hojris I, Overgaard M. Radiation heart morbidity after adjuvant
radiotherapy of early breast cancer-is it still an issue?Radiother
Oncol.2011:100:157-9.
20
[14] L.M Smyth et.al. The cardiac dose sparing benefits of deep inspiration
breath hold in left breast irradiation :a systemic review.J Med Radiation Sci
62(2015)66-73.
[15] Sardaro A, Petruzzelli MF, DErrico MP, Grimaldi L, PiliG, Portaluri M.
Radiation-induced cardiac damage in early left breast cancer patients: risk
factors,
biological
mechanisms,
radiobiology,
and dosimetric
constraints.RadiotherOncol 2012; 103: 13342.
AUTHORS
First Author Rohini Khurana MD, Associate Professor,
Department of Radiotherapy, RMLIMS, Lucknow emaildrrohinisethi@gmail.com.
Second Author Akshyaya Pradhan MD,DM, KGMU,
email- akshyaya33@gmail.com.
Third Author Sandip Barik MD, Senior resident in
Department of Radiotherapy, RMLIMS, Lucknow
email- sandip.barik1@gmail.com
Fourth Author- Kamal Sahni MD, Professor, Department of
Radiotherapy, RMLIMS, Lucknow emaildrrohinisethi@gmail.com
Correspondence Author Akshyaya Pradhan, MD, DM,
Assistant professor, Department of Cardiology, KGMU,
Lucknow. email-akshyaya33@gmail.com
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
21
Figure 1:Digitally Reconstructed Radiograph of a patient with left sided Breast Conservative Surgery in treatment position showing
target volume and organs at risk in heart and lung.
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
22
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
23
Figure 3: Comparison of two plans in terms of dose to target and heart as depicted with solid and dotted line on
DVH.
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
24
Table 1: Showing Average of mean PTV dose received by 20 pts at various points of normalization
Optimization Point
P1
49.46
P2
49.61
P3
49.11
P4
52.01
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
25
Table 2:Showing Average of mean heart dose received by 20 pts at various points of normalization.
Optimization Point
P1
5.07
P2
4.85
P3
5.0
P4
5.86
www.ijsrp.org
International Journal of Scientific and Research Publications, Volume 6, Issue 6, June 2016
ISSN 2250-3153
26
Table 3: Showing Average of mean Lung dose (D mean) and V20 received by 20 pts at various points of
normalization
Optimization Point
D mean Lung(Gy)
V20 Lung(%)
P1
10.17
18.93
P2
9.97
18.63
P3
10.62
19.84
P4
10.63
19.60
www.ijsrp.org